Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Sorafenib Active Against Hormone-Refractory Prostate Cancer
Link ID 1920
Title Sorafenib Active Against Hormone-Refractory Prostate Cancer
Url http://www.medscape.com/viewarticle/567912?src=rss
Description Sorafenib, an agent with both antiangiogenic and antiproliferative activity, may represent a useful treatment for progressive hormone-refractory prostate cancer, new research suggests. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Dec 27, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Behavioral Intervention May Promote Weight Loss in Overweight Mexican American Children
  In a randomized trial, an intensive, individualized behavorial intervention reduced body mass index at 3 and 6 months in overweight Mexican American children and teens. Medscape Medical News
Category:   Articles > Pharmacists


2. Tubal Patency Better With One Rather Than Multiple Methotrexate Doses for Ectopic Pregnancy
  In women with unruptured ectopic tubal pregnancy, treatment with single-dose rather than multiple-dose methotrexate appears to yield superior results in terms of subsequent tubal patency, according to Turkish researchers. Reuters Health Information
Category:   Articles > Pharmacists


3. Nelarabine Active Against Indolent Leukemias
  Nelarabine alone, or particularly in combination with fludarabine, appears to be useful in the treatment of relapsed and refractory indolent leukemias, according to findings from a small phase I trial. Reuters Health Information
Category:   Articles > Pharmacists


4. Pharmacology and Clinical Efficacy of Erdosteine in Chronic Obstructive Pulmonary Disease
  Erdosteine decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and a scavenging effect on free oxidant radicals.
Expert Review of Respiratory Medicine
Category:   Articles > Pharmacists


5. Pyridoxine Metabolite Does Not Improve CABG Outcomes
  Treatment with MC-1, a naturally occurring pyridoxine metabolite, does not reduce nonfatal MIs or cardiovascular deaths in intermediate- to high-risk patients undergoing coronary artery bypass grafting (CABG), the results of a randomized trial indicate. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS